At a glance
- Originator Fujisawa
- Class Anti-inflammatories
- Mechanism of Action Leucocyte elastase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Respiratory tract disorders
Most Recent Events
- 02 Oct 2001 No-Development-Reported for Respiratory tract disorders in Japan (Unknown route)
- 25 Sep 1997 New profile
- 25 Sep 1997 Phase-II clinical trials for Respiratory tract disorders in Japan (Unknown route)